Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) represented a move of 2.48 percent or $0.01 per share and closed its previous day trading session at $1.24. 801946 Shares were traded in the last trading session with an Average Volume of 589.01 Million Shares. The stock currently has a Market Capitalization of 72.63 Million.
Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions.
The stock traded between $1.20 and $2.92 over 1-Year time period showing its price to sales ratio of 3.3. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-40.12 and 200-Day Simple Moving Average of $-40.18. Its Price to Free Cash Flow is 0 and Price to Book of 1.18.
Analyst’s recommended the stock as 3.3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) reported its Actual EPS of $0.23/share. The analysts offering Earnings Estimates for the company were believing that Infinity Pharmaceuticals, Inc. could bring EPS of $-0.15/share. The difference between Actual EPS and Estimated EPS was 0.38 Percent. Thus showing an Earnings Surprise of 253.3 Percent.
Iamgold Corporation (NYSE:IAG)
In the last trading session, Iamgold Corporation (NYSE:IAG) added its value by 1.27% closing at the price of $3.2. The stock currently has market capitalization of 1.5 Billion, with average volume of 4.84 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Iamgold Corporation (NYSE:IAG) is showing beta of -0.14. This particular value of beta suggests that Iamgold Corporation (NYSE:IAG) has historically moved -14% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Iamgold Corporation (NYSE:IAG) is at $-0.03.
The stock currently has RSI of 46.99. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
IAMGOLD Corp is an international gold exploration and mining company based in Canada. It holds a 38% stake in the Sadiola Gold Mine and a 40% stake in the Yatela Gold Mine. Both are located in Mali, West Africa. Measured and indicated resources at Sadiola and Yatela are 5.5 million ounces of gold (including reserves of 5.2 million ounces). Inferred resources are 5.9 million ounces. IAMGOLD is actively exploring highly prospective ground in Africa and South America.
Iamgold Corporation (NYSE:IAG) topped its 52-week high price of $6.52 on 01/24/18 and 52-Week Low Price of $2.75 on 11/14/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 4.95% and monthly volatility of 5.52% respectively.